eClinical Tech News

PacBio reported fourth-quarter 2025 revenue of $44.6 million, up 14% year over year and 16% sequentially, with full-year revenue...

CorMedix Therapeutics will spend mid‑March on the investor circuit, hosting fireside chats at Leerink Partners and Citizens Life Sciences...

Orion reported a step-change 2025, with net sales up 22.5% to €1.89 billion and operating profit up 51.6% to...

Iovance Biotherapeutics will host its fourth quarter and full-year 2025 results call and webcast on February 24, 2026, at...

Ascendis Pharma closed 2025 with a sharp inflection in rare endocrine commercialization, reporting €684 million in product revenue for...

Veru plans to initiate a Phase 2b “Plateau” study this quarter testing enobosarm, an oral selective androgen receptor modulator,...

Exousia Pro has signed a third letter of intent to acquire an established telehealth organization, expanding a roll-up that...

Sanofi has completed its acquisition of Dynavax Technologies, adding the marketed adult hepatitis B vaccine Heplisav-B and a Phase...

Polaryx Therapeutics has unveiled late-breaking preclinical data for PLX-200, an oral formulation of gemfibrozil, in a Krabbe disease mouse...

Polyrizon, a preclinical-stage biotech developing intranasal hydrogel “biological mask” technologies, has signed a non-binding memorandum of understanding to acquire...